Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Grace Therapeutics, Inc. (GRCE) had Current Ratio of 11.47 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-15.79M |
|
-- |
|
-- |
|
$15.92M |
|
$-15.92M |
|
$0.13M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.92M |
|
$-15.91M |
|
17.27M |
|
17.27M |
|
$-0.91 |
|
$-0.91 |
|
| Balance Sheet Financials | |
$14.33M |
|
$0.01M |
|
$35.74M |
|
$50.07M |
|
$1.25M |
|
-- |
|
$0.61M |
|
$1.86M |
|
$48.21M |
|
$12.48M |
|
$48.21M |
|
16.27M |
|
| Cash Flow Statement Financials | |
$-3.22M |
|
-- |
|
-- |
|
$16.98M |
|
$13.76M |
|
$-3.22M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
11.47 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.75% |
|
-126.54% |
|
-31.53% |
|
-32.75% |
|
$2.96 |
|
$-0.19 |
|
$-0.19 |
|